The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference64 articles.
1. Decision analysis for avoiding post-chemotherapy surgery in patients with disseminated non-seminomatous germ cell tumors;Debono;J Clin Oncol,1997
2. Long-term follow-up of cisplatin combination chemotherapy in patients with disseminated non-seminomatous germ cell tumors: Is a post-chemotherapy retroperitoneal lymph node dissection needed after complete remission?;Ehrlich;J Clin Oncol,2010
3. Refining the optimal chemotherapy regimen for good-risk metastatic non-seminomatous germ cell tumors: A randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP);Culine;Ann Oncol,2007
4. Importance of bleomycin in combination chemotherapy for good-prognosis testicular non-seminoma: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group;de Wit;J Clin Oncol,1997
5. Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: Long-term follow-up;Dearnaley;Eur J Cancer,1991
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Narrative review of developing new biomarkers for decision making in advanced testis cancer;Translational Andrology and Urology;2021-10
2. Surveillance of postchemotherapy subcentimeter residual retroperitoneal mass in metastatic nonseminomatous germ cell tumor: Does how you measure matter?;Urologic Oncology: Seminars and Original Investigations;2021-02
3. Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors;Translational Andrology and Urology;2020-01
4. Advanced Testis Cancer;European Urology Focus;2019-09
5. Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor;Urology;2018-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3